SARS-COV-2 IMMUNODOMINANT PEPTIDE CONSTRUCTS AND USES THEREOF

SOLUBLE NEEDLE ARRAYS FOR DELIVERY OF INFLUENZA VACCINES

MULTIVALENT PNEUMOCOCCAL VACCINES

MULTI-ANTIGEN BACTERIAL OUTER MEMBRANE VESICLE AND USE THEREOF

ANTI-TUMOR IMMUNITY INDUCES THE PRESENTATION OF ABERRANT PEPTIDES

CHIMERIC ANTIGEN COMPRISING THE EXTRACELLULAR DOMAIN OF PD-L1

System and method directed to an eyeglasses-type wearable device

HERPESVIRUS POLYEPITOPE VACCINES

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR)-EXPRESSING CELL

NUCLEIC ACID VACCINES FOR VARICELLA ZOSTER VIRUS (VZV)

UNIVERSAL MAMMALIAN INFLUENZA VACCINE

Polysaccharide and uses thereof

APC targeting units for immunotherapy

Tumor Antigens for Determining Cancer Therapy

INFLUENZA VIRUSES WITH MUTANT PB2 GENE SEGMENT AS LIVE ATTENUATED VACCINES

TUMOR COMPLEX ANTIGEN, MULTIVALENT DENDRITIC CELL (DC) VACCINE, AND USE THEREOF

PENTAVALENT VACCINE AGAINST NEISSERIA MENINGITIDIS COMPRISING A SYNTHETIC MEN A ANTIGEN

NOVEL CORONAVIRUS TANDEM EPITOPE POLYPEPTIDE VACCINE AND USE THEREOF

A COMBINATION OF VACCINES TO PROPHYLACTICALLY TREAT A PIG

Compositions comprising polysaccharide-protein conjugates and methods of use thereof

Vaccine Compositions and Antibodies For Lyme Disease

DECTIN-1 (CLEC7A) SINGLE NUCLEOTIDE POLYMORPHISM AS A BIOMARKER FOR PREDICTING ANTIBODY RESPONSE WHEN USING BETA-GLUCAN AS A VACCINE ADJUVANT

NOROVIRUS VACCINE

MUTANT FRAGMENTS OF OSPA AND METHODS AND USES RELATING THERETO

SARS-COV2 CORONAVIRUS RECONSTITUTED RBM AND USES THEREOF

MODIFIED MYCOBACTERIUM BOVIS VACCINES

Epitope focusing by variable effective antigen surface concentration

Removal of agglomerates

NEISSERIA MENINGITIDIS VACCINE

INTRATUMORAL VACCINATION

Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof

IMMUNOGENIC COMPOSITIONS COMPRISING LAWSONIA INTRACELLULARIS

INDIVIDUALIZED THERAPEUTIC ANTICANCER VACCINE

Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 f protein and uses thereof

LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS CANCER PROTEIN ANTIGENS AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR TREATMENT OF CYTOMEGALOVIRUS

SWINE INFLUENZA A VIRUS VACCINE COMPRISING A NUCLEIC ACID CONSTRUCT HAVING A SPECIFIC ORDER OF GENES

VACCINE USING M2/BM2-DEFICIENT INFLUENZA VECTORS

COMBINATION VACCINE

COMBINATION PORCINE VACCINE

Formulation of a peptide vaccine

Henipavirus vaccine

VACCINE COMBINATION AND METHOD FOR USING THE SAME

MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME

MULTIPLE ANTIGENIC PEPTIDE AGAINST CORONAVIRUS AND IMMUNOSTIMULATING COMPOSITION CONTAINING THE SAME

ADJUVANT AND VACCINE CONTAINING ADJUVANT

Pneumococcal conjugate vaccine formulations

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

Immunogenic compositions for use in pneumococcal vaccines

PROSTATE CANCER VACCINES AND USES THEREOF

COMBINATION THERAPY WITH NEOANTIGEN VACCINE

VACCINE AGAINST SARS-COV VIRUS

Compositions and methods for dengue virus chimeric constructions in vaccines

EXOSOME-ANCHORING FUSION PROTEINS AND VACCINES

LARGE SEQUENCE PAN-CORONAVIRUS VACCINE COMPOSITIONS

Multivalent OspA polypeptides and methods and uses relating thereto

EXOSOMAL NUCLEIC ACID VACCINE MODULARLY CONFIGURED TO HARNESS MULTIPLE ANTIGEN PRESENTATION MECHANISMS

Use of the Salmonella SPP Type III Secretion Proteins as a Protective Vaccination

SALMONELLA-BASED DNA VACCINES IN COMBINATION WITH AN ANTIBIOTIC

HIGH DOSE FLU VACCINE IN PEDIATRIC SUBJECTS

THERAPEUTIC RNA FOR PROSTATE CANCER

Peptide vaccines

MULTIVALENT PNEUMOCOCCAL VACCINE COMPOSITIONS COMPRISING POLYSACCHARIDE-PROTEIN CONJUGATES

Compositions and methods of manufacturing trivalent filovirus vaccines

Multivalent pneumococcal vaccines

Vaccines against hepatitis B virus

Vaccine and Methods for Detecting and Preventing Filariasis

Methods of vaccine administration

Methods for producing capsular polysaccharide carrier protein conjugates

ACTIVE BOOSTER IMMUNIZATION AGAINST TETANUS, DIPHTHERIA AND PERTUSSIS

Methods and compositions for immune protection against extra-intestinal pathogenic

Formulations of dengue virus vaccine compositions

COMBINATION IMMUNOTHERAPIES FOR TREATMENT OF CANCER

Vaccine in combination with an immune checkpoint inhibitor for use in treating cancer

CUSTOMMUNE: A WEB TOOL FOR DESIGNING PERSONALIZED AND POPULATION-TARGETED PEPTIDE VACCINES

VACCINE CONJUGATES

MULTIVALENT HVT VECTOR VACCINE

TUMOR CELL VACCINES

System and method for virtual image adjustment

Influenza virus mutants and uses therefor

NOVEL PRIME-BOOST INFLUENZA VACCINE

SINDBIS VIRUS DNA-BASED VACCINE

NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF

STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF

NOVEL IMMUNOGENS AND METHODS FOR DISCOVERY AND SCREENING THEREOF

Therapeutic anticancer neoepitope vaccine

EHRLICHIA VACCINES AND IMMUNOGENIC COMPOSITIONS

VACCINE AND METHODS FOR DETECTING AND PREVENTING FILARIASIS

MODIFIED VESICULAR STOMATITIS VIRUS GLYCOPROTEIN AND USES THEREOF FOR THE TREATMENT OF BRAIN TUMORS

Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates

Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates

EMULSIONS WITH FREE AQUEOUS-PHASE SURFACTANT FOR ADJUVANTING SPLIT INFLUENZA VACCINES

Production of 018 bioconjugates

COMBINATION VACCINE FOR INTRADERMAL ADMINISTRATION

Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates

Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates

LIVE ATTENUATED ORAL VACCINE AGAINST SHIGELLOSIS AND TYPHOID FEVER

STABILIZED CHIMERIC SYNTHETIC PROTEINS AND THERAPEUTIC USES THEREOF

Fusion comprising a cell penetrating peptide, a multi epitope and a TLR peptide agonist for treatment of cancer

Immunogenic Antigens

COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF

HEPATITIS B VIRUS VACCINES

Immunogenic fusion protein

RNA CONSTRUCT

TREATMENT USING CHIMERIC RECEPTOR T CELLS INCORPORATING OPTIMIZED POLYFUNCTIONAL T CELLS

Influenza virus hemagglutinin proteins and uses thereof

Immunogenic composition comprising a fusion peptide derived from superantigen toxoids

Pepmixes to generate multiviral CTLS with broad specificity

Porcine circovirus type 3 immunogenic compositions and methods of making and using the same

Combination of Markers for Predicting the Response to Vx-001

Combination therapy for treating cancer with an antibody and intravenous administration of a recombinant MVA

INFLUENZA VIRUS BACKBONE

EXPANDED T CELL ASSAY

UNIVERSAL INFLUENZA VACCINE COMPOSITIONS

Alphavirus antigen vectors

Adoptive T cell therapy 2

HIV vaccines and methods of using

Feline leukemia virus vaccine

Methods and compositions for inducing immune responses against

TREATMENT METHODS

CRA4S1 GENE, ENCODED CRA4S1 PROTEIN, AND APPLICATION

Toxoplasma gondii vaccines and their use

CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR)- EXPRESSING CELL

Triple vaccine for diseases caused by and

IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF

Method and system for protecting monarch butterflies from pesticides

Vaccine against infectious bronchitis

MULTIVALENT CARRIERS AND RELATED VACCINE COMPOSITIONS

Adapted enterovirus D68 that propagates to high titer in vero cells

AUTOLOGOUS CANCER TUMOUR ASSOCIATED EXTRACHROMOSOMAL CIRCULAR DNA FOR USE AS A THERAPEUTIC VACCINE

Recombinant proteins and their therapeutic uses

CONCATEMERIC PEPTIDE EPITOPE RNAS

CANCER BIOMARKERS FOR DURABLE CLINICAL BENEFIT

MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE VACCINE

Virus-inspired compositions and methods of redirecting preexisting immune responses using the same for treatment of cancer

MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME

Multivalent Live-attenuated Influenza Vaccine for Prevention and Control of Equine Influenza Virus (EIV) in Horses

METHODS FOR PREPARING ALUMINUM PRECIPITATE COMPOUNDS FOR USE IN THERAPEUTICS AND VACCINES

Recombinant non-pathogenic Marek's disease virus constructs encoding infectious laryngotracheitis virus and infectious bursal disease virus antigens

RNA CANCER VACCINES

Recombinant influenza viruses and constructs and uses thereof

Antigenic Multimeric Respiratory Syncytial Virus Polypeptides

Immunogenic Antigens

Vaccine

Vaccine

Hepatitis C virus immunogenic compositions and methods of use thereof

COMPOSITION FOR TREATING LUNG CANCER, PARTICULARLY OF NON-SMALL LUNG CANCERS (NSCLC)

SIN NOMBRE VIRUS FULL-LENGTH M SEGMENT-BASED DNA VACCINES

Recombinant non-pathogenic Marek's disease virus constructs encoding multiple heterologous antigens

Multivalent vaccine compositions and uses thereof

SEA LICE ANTIGENS AND VACCINES

SERUM FREE INTRACELLULAR PATHOGEN VACCINE

Multivalent influenza nanoparticle vaccines

Immunogenic compositions

POPULATION-BASED IMMUNOGENIC PEPTIDE IDENTIFICATION PLATFORM

Bovine herpesvirus type 1 (BoHV-1) vector against bovine respiratory disease complex

COMPOSITIONS, METHODS AND USES FOR ELICITING AN IMMUNE RESPONSE

Compositions and methods for dengue virus chimeric constructions in vaccines

Multivalent nanoparticle-based vaccines

AFRICAN SWINE FEVER VIRUS VACCINE

Multivalent Virus Like Particle Vaccines

Tetanus toxoid and CCL3 improve DC vaccines

Protective immunity enhanced vaccine (PIESV) against spp

Multivalent feline vaccine

Influenza vaccines

Bovine rotavirus fusion protein and calf diarrhea multivalent vaccine

Immunogenic compositions and uses thereof

S-LAYER VACCINE FUSION PROTEINS AND METHODS OF USE

Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species

Neisseria meningitidis vaccine

Multivalent pneumococcal polysaccharide-protein conjugate composition

Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use

Compositions comprising polysaccharide-protein conjugates and methods of use thereof

TELEOST INVARIANT CHAIN CANCER VACCINE

Tuberculosis compositions and methods of using the same

Compositition and uses of teleost invariant chain to enhance T cell response to a vaccine

Vaccine compositions and methods of use

Multivalent live influenza vaccine platform using recombinant adenovirus

Periodontitis vaccine and related compositions and methods of use

Specific bacteria for their use as a medicament, in particular for controlling excess weight, obesity, cardiometabolic diseases and inflammatory bowel diseases

Pepmixes to generate multiviral CTLs with broad specificity

Purified capsular polysaccharides of

Multivalent pneumococcal vaccines

Combination vaccine composition comprising reduced dose inactivated poliovirus and method for preparing the same

Immunization with polyvalent venom vaccines

Composite multi-epitope expression cassette, a recombinant virus composed thereof and application thereof

INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES

COMPOSITIONS AND METHODS FOR MODIFIED DENDRIMER NANOPARTICLE DELIVERY

USES OF MODIFIED RNA ENCODING RETINALDEHYDE DEHYDROGENASE

Multiple antigen presenting immunogenic composition, and methods and uses thereof

Universal vaccine platform

Vaccine for protection against ETEC-induced diarrhea comprising dmLT

Recombinant multivalent influenza viruses

Human herpesvirus immunotherapy

Nipah virus immunogens and their use

Bacteriophage-based vaccines and engineered bacteriophage

RECOMBINANT BIOLOGICALLY CONTAINED FILOVIRUS VACCINE

Mycobacterial antigen compositions and methods of use

PROCESS FOR PREPARING PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATES

Food safety vaccine to control and reduce in poultry

ExPEC glycoconjugate vaccine formulations

Methods and Compositions for Inducing an Immune Response Against Hepatitis B Virus (HBV)

Removal of agglomerates

Vaccines against HPV and HPV-related diseases

PERSONALIZED CANCER VACCINE EPITOPE SELECTION

MULTIVALENT CMV VACCINE AND USES THEREOF

Rapid and prolonged immunologic-therapeutic

RECOMBINANT POXVIRUS BASED VACCINE AGAINST SARS-CoV-2 VIRUS

Modified meningococcal fHbp polypeptides

Immunogenic compositions and uses thereof

COMPOSITIONS AND METHODS COMPRISING MEASLES VIRUS DEFECTIVE INTERFERING PARTICLES FOR THE PREVENTION OF INFECTIOUS DISEASES

METHODS FOR PRODUCING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CARRIER PROTEIN CONJUGATES

Combination vaccine

Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres

Mixed allergen compositions and methods for using the same

Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines contaning hepatitis B virus genes

Vaccines formed by virus and antigen conjugation

Combined formulation comprising four linked cytotoxic T lymphocyte (CTL) epitopes and a PD-1 pathway inhibitor and methods of use thereof to treat cancer

Optimized host/vector system for producing protective mono- and multivalent subunit vaccines on the basis of the yeast

Combined prophylactic and therapeutic vaccines

Recombinant BCG expressing HIV-1 p24 using pMyong2 vector system and use thereof

Synthetic polypeptide epitope based vaccine composition

Multivalent Streptococcus Vaccines

COMPOSITIONS AND METHODS FOR PERSONALIZED NEOPLASIA VACCINES

Gel delivery system for treating poultry

IMMUNE CHECKPOINT INHIBITOR CO-EXPRESSION VECTORS

NEOANTIGEN TARGETING DNA VACCINE FOR COMBINATION THERAPY

Wearable device and method for visual image adjustment

Potent and balanced bidirectional promoter

Epstein-barr virus antigen constructs

Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof

Cancer-specific T-cell receptors

Porcine circovirus type 3 immunogenic compositions and methods of making and using the same

Vaccine compositions

Method and system for protecting honey bees from pesticides

MVA vaccine for delivery of a UL128 complex and preventing CMV infection

Feline leukemia virus vaccine

IMMUNE ACTIVATION TRIGGERED BY FILOVIRUS PROTEINS AND POLYPEPTIDES

INFLUENZA MRNA VACCINES

Diluent for cell-associated alphaherpesvirus vaccine

Bacterial polysaccharide-conjugated carrier proteins and use thereof

Polysaccharide and uses thereof

Mosaic HIV-1 envelopes to induce ADCC responses

HCV vaccines

Compositions and methods to treat aids

Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria

Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof

Tetravalent dengue vaccine

Vaccines for human papilloma virus and methods for using the same

Enhanced -enterotoxigenic multi-valent vaccine

Composition, preparation method and evaluation of a complex immunogen named I-SPGA for production of immunological active proteins (IAP)

IMPROVED METHODS OF MANUFACTURING PEPTIDE-BASED VACCINES

epitopes for T cell-targeted Q fever vaccines

Compositions and methods for delivery of biomacromolecule agents

compositions and methods thereof

VACCINE COMPOSITIONS

Anti-abeta therapeutic vaccines

Parenteral norovirus vaccine formulations

NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF

Neoglycoconjugates as vaccines and therapeutic tools

Fusion comprising a cell penetrating peptide, a multi epitope and a TLR peptide agonist for treatment of cancer

AMH-INH-GNIH tri-expression gene vaccine of improving fecundity of animals, preparation method and application

Multivalent pneumococcal polysaccharide-protein conjugate composition

Epitope focusing by variable effective antigen surface concentration

glycoconjugate vaccines

Genetically modified recombinant vaccinia ankara (RMVA) vaccines of improved stability and methods of preparation thereof

SEA LICE ANTIGENS AND VACCINES

Mutant fragments of OspA and methods and uses relating thereto

METHOD FOR IMPROVING THE EFFICACY OF A SURVIVIN VACCINE IN THE TREATMENT OF CANCER

HIV vaccines comprising one or more population episensus antigens

HIV vaccines comprising one or more population episensus antigens

Methods and compositions for immune protection against extra-intestinal pathogenic

Biomarkers and immunogenic compositions for filarial parasites

AipA, OmpA, and Asp14 in vaccine compositions and diagnostic targets for infection

Method and composition for treating cancer or skin lesion using a vaccine

Immunogenic compositions comprising

TICK VACCINE

composition and methods thereof

VACCINATION WITH mRNA-CODED ANTIGENS

capsular polysaccharides and conjugates thereof

Immunogenic composition comprising staphylococcal antigens

Coccidioides antigens and methods of their use

Immunogenic composition and vaccine for generating an immune response to norovirus

HER-1, HER-3 AND IGF-1R COMPOSITIONS AND USES THEREOF

Modified biotin-binding protein, fusion proteins thereof and applications

Combination HMPV/RSV RNA vaccines

compositions and methods thereof

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

Influenza peptides and compositions

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4

Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

Swine vaccine

Immunogenic compositions

Compositions and methods of manufacturing trivalent filovirus vaccines

Live attenuated oral vaccine against ETEC and typhoid fever

Intradermal combination vaccine against mycoplasma and porcine circovirus

Immunogenic compositions and uses thereof

SHARED NEOANTIGENS

Aluminum compounds for use in therapeutics and vaccines